Jamie L. Dargart MD

Pediatric Hematology & Oncology•Toledo, OH

Physician

Join to View Full Profile

2142 N Cove BlvdREN 4WToledo, OH 43606
Phone+1 419-291-9500
Fax+1 419-480-6858

Education & Training

Northwestern UniversityM.S., Clinical Investigation, 2009 - 2011
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2005 - 2008
Case Western Reserve University School of MedicineClass of 2005

Certifications & Licensure

OH State Medical License 2011 - 2027
IL State Medical License 2005 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
ACTIVE_NOT_RECRUITING
PHASE3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Start of enrollment: 2014 Oct 04
ACTIVE_NOT_RECRUITING
PHASE3
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

3 citations
Monozygotic twins diagnosed simultaneously with RAM immunophenotype acute myeloid leukemia.
Rolla Abu-Arja, Jamie L. Dargart, Rajinder P.S. Bajwa, Samir B. Kahwash, Jeffery J. Auletta
Pediatric Transplantation. 2018-12-01
6 citations
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis.
Amy E. Armstrong, Jamie L. Dargart, Jennifer Reichek, David O. Walterhouse, Debora Matossian
Pediatric Blood & Cancer. 2014-05-01
27 citations
Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.
Jamie L. Dargart, Kamonwan Fish, Leo I. Gordon, Richard Longnecker, Osman Cen
Antiviral Research. 2012-07-01

Professional Memberships

American Society of Hematology - ASH
Member
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Society of Clinical Oncology - ASCO
Member